Publishers sue US OFAC

Ban on editing and peer-reviewing material from embargoed nations challenged

Written byJohn Dudley Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A coalition of publishers' and authors' organizations sued the Department of Treasury yesterday (September 27) to force it to stop banning the American publication of works written by authors in four trade-embargoed countries.

The federal lawsuit filed in New York City asks for a temporary injunction against the Treasury's Office of Foreign Assets Control (OFAC), which regulates ongoing US embargoes against Iran, Cuba, Libya, and Sudan. The regulations violate the First Amendment and US law, publishers claim, because they require them to obtain government licenses before they can "substantively edit" manuscripts before publication.

(As of April 29, the regulations on Libya changed so that most activities are now legal, including performing services for Libyans and the Libyan government.)

Manuscripts from embargoed nations that need no editing can be published as is, because Americans haven't aided an embargoed country by improving them. Violators can potentially be fined up to $1 million ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform